The burden of the complications of diabetes mellitus

Article Sidebar

PDF
Published: Aug 8, 2016
DOI: https://doi.org/10.18051/UnivMed.2016.v35.65-67 Universa Medicina
Abstract Viewed: 509
PDF Downloaded: 155

Main Article Content

Adi Hidayat
Department of Community Medicine Faculty of Medicine, Trisakti University

Abstract

Diabetes mellitus (DM) is an important global cause of mortality, morbidity, and health-system costs,(1,2) with significant increases in its prevalence and number of cases in the last 30 years. It constitutes one of the four non communicable diseases (NCDs) targeted for action by world leaders.According to WHO estimates, in 2014 there were 422 million adults with DM aged 18 years or older, with around half in the WHO South-East Asia and Western Pacific Regions.(3) The prevalence of DM and the number of adults with DM in low- and middle-income countries have over the last decade increased at a greater rate than in high-income countries. The global DM prevalence increased by more than 100% in men and by 60% in women, resulting in a predominance of males with DM in 2014 as compared with a higher DM female prevalence in 1980.

Article Details

How to Cite
Hidayat, A. (2016). The burden of the complications of diabetes mellitus. Universa Medicina, 35(2), 65–67. https://doi.org/10.18051/UnivMed.2016.v35.65-67
Issue
Vol. 35 No. 2 (2016)
Section
Editorial

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014;2: 634–47.

Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics 2015;33: 811–31.

World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.

Wandell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden—a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract 2014;106:e90–2.

Pusat Data dan Informasi Kementerian Kesehatan R.I. Situasi dan analisis diabetes. Jakarta; Pusat Data dan Informasi Kementerian Kesehatan R.I;2015.

GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287–323.

NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016;387:1377–96.

Alharbi NS, Almutari R, Jones S, et al. Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis. Diabetes Res Clin Pract 2014;106:e30–33.

Farzadfar F, Murray CJ, Gakidou E, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet 2012; 379:47–54.

Smith-Spangler CM1, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care 2012;35: 319–26.

International Diabetes Federation. Diabetes atlas, 6th ed. Brussels, International Diabetes Federation;2014.

McIntyre HD. Dose adjustment for normal eating: a role for the expert patient? Diabetes Metab J 2014;38:87-91. http://dx.doi.org/10.4093/dmj.2014.38.2.8.